M

Researcher Profile

Michael Deininger

3

Publications

2,035

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Leukemia Mar 22, 2023

Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

Michael J. Mauro · Timothy P. Hughes · Dong-Wook Kim · Delphine Rea +22 more

10.1038/s41375-023-01860-w 47 citations

Journal Article Nature Medicine Oct 26, 2020

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

Amy Burd · Ross L. Levine · Amy S. Ruppert · Alice S. Mims +36 more

10.1038/s41591-020-1089-8 172 citations

Journal Article New England Journal of Medicine Mar 01, 2012

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srdan Verstovsek · Ruben A. Mesa · Jason Gotlib · Richard S. Levy +20 more

10.1056/nejmoa1110557 1,816 citations

Publication Timeline

2023

1

2020

1

2012

1

Frequent Co-Authors

Matthew C. Foster

Naranie Shanmuganathan

Andreas Hochhaus

Jimmie H. Harvey